TG THERAPEUTICS, INC. Business Finance Contracts & Agreements
56 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (3)
- Debenture Agreements (1)
- Exchange Agreements (3)
- Forbearance Agreements (1)
- Loan Agreements (3)
- Note Agreements (3)
- Purchase Agreements (1)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (10)
- Subscription Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (20)
- Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Global Venture Growth Fund I L.P (Filed With SEC on May 8, 2023)
- Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P (Filed With SEC on May 8, 2023)
- Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Capital Inc (Filed With SEC on May 8, 2023)
- Amended and Restated Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Global Venture Growth Fund I L.P (Filed With SEC on May 8, 2023)
- Amended and Restated Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P (Filed With SEC on May 8, 2023)
- Amended and Restated Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Funding IV, LLC (Filed With SEC on May 8, 2023)
- Amended and Restated Warrant Agreement, dated March 31, 2023, by and between TG Therapeutics, Inc. and Hercules Capital Inc (Filed With SEC on May 8, 2023)
- First Amendment to Amended and Restated Loan and Security Agreement, dated March 31, 2023, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc (Filed With SEC on May 8, 2023)
- Warrant Agreement, dated December 30, 2021, by and between TG Therapeutics, Inc. and Hercules Private Global Venture Growth Fund I L.P (Filed With SEC on March 1, 2022)
- Warrant Agreement, dated December 30, 2021, by and between TG Therapeutics, Inc. and Hercules Private Credit Fund I L.P (Filed With SEC on March 1, 2022)
- Warrant Agreement, dated December 30, 2021, by and between TG Therapeutics, Inc. and Hercules Capital Inc (Filed With SEC on March 1, 2022)
- Amended and Restated Loan and Security Agreement, dated December 30, 2021, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc (Filed With SEC on March 1, 2022)
- Loan and Security Agreement, dated February 28, 2019, by and among TG Therapeutics, Inc., TG Biologics, Inc. and Hercules Capital, Inc (Filed With SEC on March 5, 2019)
- Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Technology III, L.P (Filed With SEC on March 5, 2019)
- Warrant Agreement, dated February 28, 2019, by and between TG Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on March 5, 2019)
- Underwriting Agreement, dated March 1, 2019, by and between TG Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on March 5, 2019)
- UNDERWRITING AGREEMENT between TG THERAPEUTICS, INC. and JEFFERIES LLC as Representative of the Several Underwriters (Filed With SEC on March 9, 2017)
- AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENTS (Filed With SEC on January 7, 2015)
- AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENTS (Filed With SEC on January 7, 2015)
- AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENT (Filed With SEC on November 14, 2014)
- STOCKHOLDER PROTECTION RIGHTS AGREEMENT dated as of July 18, 2014 between TG THERAPEUTICS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY,LLC as Rights Agent (Filed With SEC on July 21, 2014)
- AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENT (Filed With SEC on November 15, 2013)
- AMENDMENT TO RESTRICTED STOCK AGREEMENT (Filed With SEC on July 16, 2013)
- AMENDMENT TO RESTRICTED STOCK AGREEMENT (Filed With SEC on July 16, 2013)
- TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on June 21, 2013)
- SECURITIES EXCHANGE AGREEMENT (Filed With SEC on November 13, 2012)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 13, 2012)
- AMENDMENT NO. 1 TO EXCHANGE TRANSACTION AGREEMENT (Filed With SEC on August 8, 2012)
- WARRANT TO PURCHASE COMMON STOCK OF Manhattan Pharmaceuticals, Inc. (Filed With SEC on March 14, 2012)
- RESTRICTED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on March 14, 2012)
- RESTRICTED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on March 14, 2012)
- EXCHANGE TRANSACTION AGREEMENT (Filed With SEC on January 5, 2012)
- ARISTON PHARMACEUTICALS, INC. Amended and Restated Convertible Promissory Note (Filed With SEC on March 7, 2011)
- WAIVERAND FORBEARANCE AGREEMENT (Filed With SEC on February 14, 2011)
- MANHATTANPHARMACEUTICALS, INC. WARRANT (Filed With SEC on November 3, 2009)
- MANHATTANPHARMACEUTICALS, INC. 12% Original Issue DiscountSenior Subordinated Convertible Debenture (Filed With SEC on November 3, 2009)
- AMENDMENTNO. 1 TO REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 10, 2009)
- MANHATTAN PHARMACEUTICALS, INC. FORM OF WARRANT (Filed With SEC on November 25, 2008)
- Underwriting Agreement, dated December 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Cantor... (Filed With SEC on December 16, 2020)
- Underwriting Agreement, dated May 14, 2020, by and among TG Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, Evercore Group L.L.C. and Cantor Fitzgerald & Co., as... (Filed With SEC on May 18, 2020)
